

Fast-Track Moderna’s HSV-2 Vaccine & Fund HSV Cure Research at Fred Hutch


Fast-Track Moderna’s HSV-2 Vaccine & Fund HSV Cure Research at Fred Hutch
The Issue
Herpes simplex virus type 2 (HSV-2) affects an estimated 500 million people globally, causing painful genital outbreaks, stigma, and a heightened risk of HIV transmission. Despite the massive public health burden, there is still no approved vaccine or cure for genital herpes.
What’s New: A Promising HSV-2 Vaccine from Moderna
Moderna’s investigational mRNA-1608 vaccine is showing unprecedented promise:
- 100% protection against lethal HSV-2 challenge in animal models
- No detectable latent virus in sensory neurons post-vaccination
- Dramatic reduction in viral shedding and transmission potential
- Strong safety and immune response in ongoing human trials (Phase 1/2)
This could be the first true HSV vaccine—but only if it gets the attention, funding, and fast-tracking it needs.
Fred Hutch’s Role in the Cure, Meanwhile, Fred Hutchinson Cancer Center and other top U.S. research institutions are leading foundational studies into:
- Herpes latency and immune escape
- Therapeutic vaccine strategies
- mRNA platforms and viral immunology
What We’re Demanding:
- Fast-track FDA review of Moderna’s mRNA-1608 vaccine
- Authorize Emergency Use pathways if human safety and immune data support it
- Substantially increase federal research funding (via NIH, BARDA, etc.) for HSV vaccines, cures, and latency reversal
- Create donation-friendly channels to fund labs like Fred Hutch and HSV-focused biotech companies
- Coordinate public-private partnerships to accelerate Phase 3 trials, manufacturing, and global access
Why This Matters:
- HSV-2 causes lifelong pain, stigma, and emotional trauma
- A vaccine or cure could prevent millions of new infections and reduce HIV risk
- HSV research is underfunded and overlooked, despite the scale of suffering
- We have the technology and momentum—we just need leadership and investment
Join Us
Help us reach 100,000 signatures so that the FDA, NIH, Congress, and the White House hear our call:
- Support HSV-2 vaccine development and fund a cure.
Let’s end the silence around herpes. Let’s demand action. Let’s fight for health, dignity, and hope.
94
The Issue
Herpes simplex virus type 2 (HSV-2) affects an estimated 500 million people globally, causing painful genital outbreaks, stigma, and a heightened risk of HIV transmission. Despite the massive public health burden, there is still no approved vaccine or cure for genital herpes.
What’s New: A Promising HSV-2 Vaccine from Moderna
Moderna’s investigational mRNA-1608 vaccine is showing unprecedented promise:
- 100% protection against lethal HSV-2 challenge in animal models
- No detectable latent virus in sensory neurons post-vaccination
- Dramatic reduction in viral shedding and transmission potential
- Strong safety and immune response in ongoing human trials (Phase 1/2)
This could be the first true HSV vaccine—but only if it gets the attention, funding, and fast-tracking it needs.
Fred Hutch’s Role in the Cure, Meanwhile, Fred Hutchinson Cancer Center and other top U.S. research institutions are leading foundational studies into:
- Herpes latency and immune escape
- Therapeutic vaccine strategies
- mRNA platforms and viral immunology
What We’re Demanding:
- Fast-track FDA review of Moderna’s mRNA-1608 vaccine
- Authorize Emergency Use pathways if human safety and immune data support it
- Substantially increase federal research funding (via NIH, BARDA, etc.) for HSV vaccines, cures, and latency reversal
- Create donation-friendly channels to fund labs like Fred Hutch and HSV-focused biotech companies
- Coordinate public-private partnerships to accelerate Phase 3 trials, manufacturing, and global access
Why This Matters:
- HSV-2 causes lifelong pain, stigma, and emotional trauma
- A vaccine or cure could prevent millions of new infections and reduce HIV risk
- HSV research is underfunded and overlooked, despite the scale of suffering
- We have the technology and momentum—we just need leadership and investment
Join Us
Help us reach 100,000 signatures so that the FDA, NIH, Congress, and the White House hear our call:
- Support HSV-2 vaccine development and fund a cure.
Let’s end the silence around herpes. Let’s demand action. Let’s fight for health, dignity, and hope.
94
The Decision Makers



Supporter Voices
Petition Updates
Share this petition
Petition created on May 19, 2025
